Kinetic Concepts' CelluTome Epidermal Harvesting System now commercially available in Europe

NewsGuard 100/100 Score

Kinetic Concepts, Inc. today launched its CelluTome™ Epidermal Harvesting System in Europe. The CelluTome™ System provides an automated, precise and reproducible process of harvesting autologous epidermal tissue for grafting that has been shown to aid closure of acute and chronic wounds.

"This technology is revolutionary because, for the first time, it takes grafting outside the OR and allows us to perform epidermal grafting in a minimally invasive way," said Keith Harding, CBE, FRCGP, FRCP, FRCS, Dean of Clinical Innovation, Cardiff University School of Medicine. "It enhances our ability to help chronic wounds close when historically these have been difficult and time-consuming to treat."

In mid June, approximately 300 healthcare professionals from across Europe, the Middle East and Asia attended the International Surgical Wound Forum (ISWF) in Edinburgh, Scotland. As part of a comprehensive clinical program, participants learnt about the science and process for epidermal grafting using micrografts harvested with the CelluTome™ System and discussed patient case studies.

"Using epidermal micrografts harvested with the CelluTome™ System, we now have the ability to promote healing and wound closure over freshly granulated tissue with minimal damage to the donor site," said Ron Silverman, M.D., chief medical officer, KCI. "For patients, this means that we aren't creating a new wound to save another."

The CelluTome™ System enables wound care physicians to harvest and facilitate epidermal grafts, while minimizing donor site complications. The simplicity of the system makes the benefits of epidermal grafting accessible to a much broader range of clinicians and patients than before.

Source:

Kinetic Concepts Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Are your snacks deadly? New study reveals how ultra-processed foods lead to chronic disease outcomes